Core Insights - The OCIN 2025 conference in Shanghai showcased advancements in neurointerventional technology, highlighting the collaboration between OCIN and WLNC to create a global platform for cerebrovascular disease discussions [1] - The introduction of the "Great Wall" and "Ruyi" stents represents significant innovations in domestic medical devices, emphasizing China's capability in producing advanced medical technology [4][6] Product Innovations - The "Great Wall" stent is the first domestic intracranial aneurysm embolization assist device, designed to optimize treatment for small distal vessels using a 17 French microcatheter [4][12] - The "Ruyi" stent is the first coated mesh stent in China, featuring a polyphosphazene coating and a nickel-titanium balloon design, enhancing compatibility with a 21 French system [4][21] - Both stents demonstrate China's ability to meet clinical needs while leading technological innovation, showcasing resilience and commitment to patient care [6][23] Clinical Applications - The "Great Wall" stent's design allows for precise deployment through small diameter catheters, making it suitable for treating complex aneurysms [12][16] - The "Ruyi" stent's design facilitates smooth delivery and rapid deployment, significantly shortening the learning curve for clinicians [21][23] - The CATCH technology, a new aspiration technique, enhances the efficiency and safety of thrombectomy procedures, marking a significant advancement in the field [36][40] International Collaboration - The conference attracted over 20 top neurointerventional experts from countries like Mongolia, Kazakhstan, Singapore, and Thailand, fostering international dialogue on advancements in neurointervention [53] - The discussions highlighted the potential of China's innovations, such as the CATCH technology, to provide new solutions for global thrombectomy practices [45]